| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | President, CEO
1 company
Vaddi Krishna is a CEO at Prelude Therapeutics Inc. Recent SEC Form 4 filings include 15 buys and 0 sells.
Estimated insider holdings value: $8.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2025 | PRLD Prelude Therapeutics Inc | CEO | Buy | 675,000 | $0.69 | $467,437.50 | +51.0% | +20.8% | +368.8% | |
| Mar 21, 2025 | PRLD Prelude Therapeutics Inc | CEO | Buy | 20,416 | $0.73 | $14,909.43 | +0.8% | +21.1% | +320.8% | |
| Mar 17, 2025 | PRLD Prelude Therapeutics Inc | CEO | Buy | 39,105 | $0.75 | $29,459.84 | +1.5% | +29.0% | +354.4% | |
| Mar 13, 2025 | PRLD Prelude Therapeutics Inc | CEO | Buy | 97,500 | $0.71 | $69,564.00 | +4.1% | +54.9% | +366.8% | |
| Dec 31, 2024 | PRLD Prelude Therapeutics Inc | CEO | Buy | 5,000 | $1.21 | $6,043.50 | +3.6% | -39.8% | +127.5% | |
| Dec 30, 2024 | PRLD Prelude Therapeutics Inc | CEO | Buy | 10,000 | $1.20 | $12,000.00 | +7.8% | -36.5% | +134.7% | |
| Dec 19, 2024 | PRLD Prelude Therapeutics Inc | CEO | Buy | 106,888 | $0.93 | $99,325.86 | +9.0% | -17.0% | +141.0% | |
| May 25, 2023 | PRLD Prelude Therapeutics Inc | CEO | Buy | 1,900 | $5.15 | $9,790.40 | - | -34.6% | -22.2% | |
| May 23, 2023 | PRLD Prelude Therapeutics Inc | CEO | Buy | 11,856 | $5.63 | $66,749.28 | +1.1% | -38.7% | -24.4% | |
| Dec 20, 2022 | PRLD Prelude Therapeutics Inc | CEO | Buy | 19,188 | $5.13 | $98,445.95 | +18.9% | +35.1% | -20.3% |